Wellcome-Lancet Commission

Contents

Wellcome-Lancet Commission

The Wellcome-Lancet Commission was a multidisciplinary commission convened by Wellcome Trust and The Lancet to examine major challenges in global health. It brought together scholars, practitioners, and policymakers from institutions including Harvard University, World Health Organization, University of Oxford, and Imperial College London to produce synthesis reports influencing policy debates at venues such as the World Health Assembly and United Nations General Assembly. The Commission's work intersected with actors like Bill & Melinda Gates Foundation, Médecins Sans Frontières, Centers for Disease Control and Prevention, and Gavi, the Vaccine Alliance.

Background and Establishment

The Commission was established amid debates shaped by events such as the Ebola virus epidemic in West Africa and the 2014–2016 Ebola outbreak, responses coordinated by Doctors Without Borders and assessed by panels including members from London School of Hygiene & Tropical Medicine and Johns Hopkins Bloomberg School of Public Health. Founding discussions involved representatives from National Institutes of Health, Global Fund to Fight AIDS, Tuberculosis and Malaria, World Bank, and major universities like Stanford University and University of Cambridge. Early framing drew on previous initiatives including the Commission on Social Determinants of Health and reports from Institute of Medicine panels, and aligned with Sustainable Development Goals deliberations at the United Nations.

The Commission aimed to define priorities across areas such as pandemic preparedness, research funding, and health systems resilience, engaging stakeholders including European Commission, African Union, G20, and national ministries from countries like United Kingdom, United States, India, and China. Objectives encompassed evaluation of financing mechanisms linked to entities such as International Monetary Fund, Organisation for Economic Co-operation and Development, and philanthropic partners like Rockefeller Foundation. Scope included interactions with global initiatives like COVAX and agencies such as UNAIDS and UNICEF.

Major reports produced by the Commission synthesized evidence from case studies such as the 2003 SARS outbreak, 2009 swine flu pandemic, and the Zika virus epidemic. Findings highlighted gaps in surveillance systems discussed by Centers for Disease Control and Prevention and capacity shortfalls in regions represented by African Centres for Disease Control and Prevention and Pan American Health Organization. Reports recommended reforms resonant with policy frameworks advocated by Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation, and research roadmaps similar to those from Coalition for Epidemic Preparedness Innovations.

The Commission organized thematic working groups drawing expertise from institutions like Massachusetts Institute of Technology, Yale University, Karolinska Institutet, University of Toronto, and think tanks such as Chatham House and Brookings Institution. Methodology combined systematic review approaches pioneered at Cochrane Collaboration with modeling techniques used at Imperial College London and Institute for Health Metrics and Evaluation. Working groups addressed governance, financing, technological innovation involving partners like Wellcome Trust Sanger Institute and European Medicines Agency, and legal frameworks intersecting with entities like World Trade Organization.

Commission outputs influenced policy dialogues at forums including World Health Assembly, G20 Summit, and UN General Assembly high-level meetings. Recommendations were referenced by agencies such as World Health Organization, United Nations Development Programme, and bilateral donors including Department for International Development (UK) and United States Agency for International Development. The Commission catalyzed collaborations with research consortia at University of California, Berkeley, University of Melbourne, and networks including African Academy of Sciences and Asian Development Bank projects.

Critics from organizations such as Médecins Sans Frontières and commentators in outlets like The New York Times and The Guardian questioned aspects of independence given funding ties to institutions including Wellcome Trust and philanthropic influence from groups like Bill & Melinda Gates Foundation. Debates invoked precedents from inquiries such as the Commission on the Financing of Global Public Goods and controversies around intellectual property rights seen in disputes involving World Trade Organization negotiations and TRIPS Agreement. Some scholars from London School of Economics and University of Cape Town argued the Commission underweighted community-led models promoted by Partners In Health.

The Commission's legacy persists through citations in reports by World Health Organization, policy briefs by Chatham House, and incorporation into curricula at Harvard T.H. Chan School of Public Health and London School of Hygiene & Tropical Medicine. Follow-on initiatives engaged funders like Wellcome Trust and multilateral actors including World Bank Group and Asian Development Bank to implement recommendations via programs at Coalition for Epidemic Preparedness Innovations and partnerships with Gavi, the Vaccine Alliance. Ongoing scholarly work at centers such as Johns Hopkins Center for Health Security and Global Health Security Agenda networks continues to draw on the Commission's frameworks.

Category:Commissions